跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PRIVA-MONTELUKAST - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PRIVA-MONTELUKAST
Authorized
STANDARD
PRIVA-MONTELUKAST
pharmapar inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
04f27919d1c568bf
Company
pharmapar inc
Type
Standard
Approval Details
Approval Id
04f27919d1c568bf
Drug Approval Canada Name
PRIVA-MONTELUKAST
Product Name
PRIVA-MONTELUKAST
Status
Cancelled Post Market
Status Date
2022-07-29
Original Market Date
2018-11-07
Din
02440350
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
48:10.24
Atc Original
R03DC03 MONTELUKAST
Atc Name
r 03 dc 03
Aig Number
0133823002
Company Name
pharmapar inc
Company Address
1565 Boul Lionel-Boulet, Varennes, Quebec, Canada, J3X 1P7
Active Ingredients
MONTELUKAST (MONTELUKAST SODIUM)
10 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
04f27919d1c568bf
Type
Standard
Back to Health Canada Approvals